Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8614101 In situ lysis of cells in lateral flow immunoassays

Patent 8614101 was granted and assigned to Rapid Pathogen Screening on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Rapid Pathogen Screening

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86141010

Date of Patent

December 24, 2013

Patent Application Number

125026620

Date Filed

July 14, 2009

Patent Citations Received

‌

US Patent 12123002 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

‌

US Patent 12078636 Selective white blood cell lysis for immunoassay systems

‌

US Patent 12084659 Modulatory polynucleotides

‌

US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)

‌

US Patent 11697825 Compositions and methods for the production of scAAV

‌

US Patent 11752181 Compositions and methods of treating Huntington's disease

‌

US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease

‌

US Patent 11931375 Treatment of amyotrophic lateral sclerosis (ALS)

...

Patent Primary Examiner

‌

Chris L Chin

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8614101 In situ lysis of cells in lateral flow immunoassays

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API